Finance, Pharmaceuticals and Team

How Big Data Brings Marketing and Finance Together

Harvard Business Review

JULY 17, 2014

Rajamannar involved finance early. To spearhead analytic efforts, he assigned a finance person – who was already embedded in marketing – to create an ROI evaluation framework and integrated her deeper into the marketing function. MasterCard had always been a data-driven organization. Inside Intel. The result has been transformational.

Finance

Finance Marketing P&L ROI

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. FREE StrategyDriven Trial Membership.

Tactics

Tactics Execution Pharmaceuticals Human Capital

Introducing 100 Coaches: Pay It Forward Champions

Marshall Goldsmith

FEBRUARY 8, 2018

Rod MacKenzie – Executive Vice President, Chief Development Officer for Pfizer, member of Pfizer’s Executive Leadership Team. Darek Lenart – Senior VP HR, Finance MasterCard. Former HR director with Pepsi Central Eastern Europe, and gained HR expertise at PLIVA Pharmaceutical Company (now part of Teva Group).

Executive Coaching

Executive Coaching CEO Magazine Banking

The Rise of the COO

Harvard Business Review

NOVEMBER 9, 2011

That's what we found when we studied the top management teams of companies in Europe over the past three years. Part of the problem may be in the backgrounds that companies desired: 85% of COOs had experience in operations, strategy, or finance. Does your COO have the best shot at becoming the next CEO?

COO

COO Sample Telecommunications Automotive

This Pharma Company Stays Innovative by Doing Two Things

Harvard Business Review

MARCH 14, 2017

When one of us (Vivek) and his team launched Roivant Sciences in 2014 and began developing treatments for Alzheimer’s disease — they were determined to learn from the pharma industry’s innovation issues and build a more sustainable innovation engine. Roivant’s first response was to address misaligned incentives.

Innovation

Innovation Company Incentives Industry

Corporate Learning Programs Need to Consider Context, Not Just Skills

Harvard Business Review

NOVEMBER 10, 2017

In one pharmaceutical R&D company, we identified three critical populations that needed to change to enable the execution of the organization’s strategy. ” Because this approach affected the way the auditors executed their work, the on-the-ground impact and the effectiveness of the audit team improved dramatically.

Skills

Skills Agility Learning-by-Doing Content

First-Time Managers, Don’t Do Your Team’s Work for Them

Harvard Business Review

SEPTEMBER 21, 2015

Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. But problems arise when there’s no ongoing dialogue with team members, peers, and bosses about the definition of “success” and “results”— and who is responsible for what.

Management

Management Pharmaceuticals Learning-by-Doing Marketing

The Questions Executives Should Ask About 3D Printing

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Carmakers have started using 3D technology to produce parts. And last year saw the first demonstration of a digital printer producing multilayer, standards-based circuit boards.

Supply Chain

Supply Chain Execution Analysis Technology

Social Media Compliance Isn't Fun, But It's Necessary

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. "Follow us here for updates on our work, our research, and our people.".

Compliance

Compliance Media Compliance Officer Policies

The Right Way to Use Analytics Isn’t for Planning

Harvard Business Review

JUNE 16, 2016

Pharmaceutical companies spend millions upon millions preparing meticulous plans for new drug launches – and yet their route-to-market strategies haven’t changed in decades, even though the reality of the market has. The failure stemmed from resistance in the U.S. What builds management perspectives?

Planning

Planning Competitive Intelligence Pharmaceuticals Brand

How to Know If a Spin-Off Will Succeed

Harvard Business Review

FEBRUARY 24, 2015

Does the business have a complete, balanced, and cohesive management team? Successful spin-offs tend to have a management team that comprises both insiders and outsiders. The outsiders provide new blood in support functions such as finance, legal, or administration. and the competitive intensity of its industry.

Chemicals

Chemicals How To Kahneman Reputation

New Lessons from Fighting an Ancient Disease

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Three people die every minute from tuberculosis — a treatable and largely preventable disease.

Health Care

Health Care ROI NGO Long-term

Don't Confuse a Scorecard with a Scoreboard

Harvard Business Review

SEPTEMBER 13, 2011

Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago. She also found that some sales teams were able to hit their numbers despite these factors.

Short-term

Short-term Pharmaceuticals Long-term Maturity

Business Needs to Do What Government Can't

Harvard Business Review

FEBRUARY 4, 2013

The future, he argued, lies with institutional forms based on networks, "an open, fluid team of teams". Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance. Breakthrough Access. Breakthrough involves a shift to new types of impact investment.

EPS

EPS Innovation CEO Pharmaceuticals

What Does It Mean to Sell? Ask the U.S. Supreme Court

Harvard Business Review

APRIL 23, 2012

Supreme Court is expected to rule on whether the work done by pharmaceutical salespeople really counts as "selling." pharmaceutical industry could face billions in retroactive overtime. By any reasonable definition, pharmaceutical salespeople are absolutely salespeople. SmithKline Beecham Corp. By June, the U.S.

Pharmaceuticals

Pharmaceuticals Banking Objective Incentives

Many CEOs Aren’t Breakthrough Innovators (and That’s OK)

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO

CEO Innovation Pharmaceuticals Merchandising

The Internet of Things Will Change Your Company, Not Just Your Products

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. It also took into account their roles in changing patient behavior.

Productivity

Productivity Products Company Engineering

What a Changing NAFTA Could Mean for Doing Business in Mexico

Harvard Business Review

JUNE 20, 2017

Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards. Multinationals are heavily pushing for either minor tweaking to the agreement or a modernization of NAFTA.

Supply Chain

Supply Chain Depreciation Uncertainty Marketing

7 Charts Show How Political Affiliation Shapes U.S. Boards

Harvard Business Review

AUGUST 23, 2016

Both Republicans and Democrats say the most effective board committee is audit/finance. More Republicans consider themselves to be very good at negotiation, while more Democrats consider themselves to be very good at building teams. We found differences in how Republican and Democrat directors view the performance of their boards.

Politics

Politics Committee Telecommunications Diversity

Leadership Digital

How Big Data Brings Marketing and Finance Together

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Trending Sources

Introducing 100 Coaches: Pay It Forward Champions

The Rise of the COO

This Pharma Company Stays Innovative by Doing Two Things

Corporate Learning Programs Need to Consider Context, Not Just Skills

First-Time Managers, Don’t Do Your Team’s Work for Them

The Questions Executives Should Ask About 3D Printing

Social Media Compliance Isn't Fun, But It's Necessary

The Right Way to Use Analytics Isn’t for Planning

How to Know If a Spin-Off Will Succeed

New Lessons from Fighting an Ancient Disease

Don't Confuse a Scorecard with a Scoreboard

Business Needs to Do What Government Can't

What Does It Mean to Sell? Ask the U.S. Supreme Court

Many CEOs Aren’t Breakthrough Innovators (and That’s OK)

The Internet of Things Will Change Your Company, Not Just Your Products

What a Changing NAFTA Could Mean for Doing Business in Mexico

7 Charts Show How Political Affiliation Shapes U.S. Boards

Stay Connected